A Andreana

2.0k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

A Andreana is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, A Andreana has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in A Andreana's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (6 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). A Andreana is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (6 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). A Andreana collaborates with scholars based in Italy and United States. A Andreana's co-authors include Riccardo Utili, Giuseppe Ruggiero, Marie‐Françoise Tripodi, Luigi Elio Adinolfi, Michele Gambardella, Enrico Ragone, Emanuele Durante‐Mangoni, Maria Giordano, G. Cesaro and Luigi Elio Adinolfi and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and The Journal of Infectious Diseases.

In The Last Decade

A Andreana

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Steatosis Accelerates the Progression of Liver Damage of Chronic Hepatitis C Patients and Correlates With Specific Hcv Genotype and Visceral Obesity

2001 860 citations Luigi Elio Adinolfi, Michele Gambardella et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Andreana Italy	15	1.2k	1.0k	161	128	95	28	1.6k
Wen‐Yu Chang Taiwan	20	1.0k 0.8×	1.1k 1.0×	129 0.8×	88 0.7×	93 1.0×	48	1.4k
Dominique Capron France	17	830 0.7×	701 0.7×	94 0.6×	107 0.8×	149 1.6×	43	1.1k
Ming‐Yuh Hsieh Taiwan	25	1.8k 1.4×	1.9k 1.8×	145 0.9×	88 0.7×	117 1.2×	72	2.2k
Yoshihiko Yano Japan	23	1.0k 0.8×	897 0.9×	135 0.8×	151 1.2×	155 1.6×	152	1.7k
Sergi Ampurdanés Spain	18	1.5k 1.2×	1.5k 1.5×	118 0.7×	90 0.7×	36 0.4×	27	1.8k
Anuchit Chutaputti Thailand	16	2.2k 1.7×	2.0k 1.9×	127 0.8×	176 1.4×	125 1.3×	30	2.6k
Gerald Minuk Canada	5	2.0k 1.6×	2.0k 1.9×	168 1.0×	67 0.5×	171 1.8×	8	2.3k
Hakan Bozkaya Türkiye	25	1.7k 1.4×	1.6k 1.6×	129 0.8×	96 0.8×	52 0.5×	83	2.1k
Michele Gambardella Italy	11	994 0.8×	796 0.8×	100 0.6×	131 1.0×	95 1.0×	27	1.3k
Emilia Hadziyannis Greece	24	1.4k 1.2×	1.2k 1.2×	203 1.3×	149 1.2×	33 0.3×	76	1.8k

Countries citing papers authored by A Andreana

Since Specialization

Citations

This map shows the geographic impact of A Andreana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Andreana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Andreana more than expected).

Fields of papers citing papers by A Andreana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Andreana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Andreana. The network helps show where A Andreana may publish in the future.

Co-authorship network of co-authors of A Andreana

This figure shows the co-authorship network connecting the top 25 collaborators of A Andreana. A scholar is included among the top collaborators of A Andreana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Andreana. A Andreana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daniele, Bruno, Ilario de Sio, Francesco Izzo, et al.. (2003). Hepatic Resection and Percutaneous Ethanol Injection as Treatments of Small Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 36(1). 63–67. 44 indexed citations

Durante‐Mangoni, Emanuele, Luigi Elio Adinolfi, Marie‐Françoise Tripodi, et al.. (2003). Risk factors for “major” embolic events in hospitalized patients with infective endocarditis. American Heart Journal. 146(2). 311–316. 90 indexed citations

Tripodi, Marie‐Françoise, Luigi Elio Adinolfi, A Andreana, et al.. (2001). Treatment of pulmonary nocardiosis in heart‐transplant patients: importance of susceptibility studies. Clinical Transplantation. 15(6). 415–420. 14 indexed citations

Adinolfi, Luigi Elio, Michele Gambardella, A Andreana, et al.. (2001). Steatosis Accelerates the Progression of Liver Damage of Chronic Hepatitis C Patients and Correlates With Specific Hcv Genotype and Visceral Obesity. Hepatology. 33(6). 1358–1364. 860 indexed citations breakdown →

Adinolfi, Luigi Elio, Riccardo Utili, A Andreana, et al.. (2001). Serum HCV RNA Levels Correlate with Histological Liver Damage and Concur with Steatosis in Progression of Chronic Hepatitis C. Digestive Diseases and Sciences. 46(8). 1677–1683. 84 indexed citations

Tripodi, M., et al.. (2001). Comparative Activities of Isepamicin, Amikacin, Cefepime, and Ciprofloxacin Alone or in Combination with Other Antibiotics Against Stenotrophomonas maltophilia. European Journal of Clinical Microbiology & Infectious Diseases. 20(1). 73–75. 10 indexed citations

Adinolfi, Luigi Elio, Maria Giordano, A Andreana, et al.. (2001). Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. British Journal of Haematology. 113(3). 590–595. 167 indexed citations

Adinolfi, Luigi Elio, Riccardo Utili, A Andreana, et al.. (2000). Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology. 12(3). 299–304. 46 indexed citations

Utili, Riccardo, Rosa Zampino, Ciro Maiello, et al.. (2000). Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment. Clinical Transplantation. 14(4). 282–286. 9 indexed citations

10.

Tripodi, M., et al.. (1998). Successful Treatment with Ampicillin and Fluoroquinolones of Human Endocarditis due to High-Level Gentamicin-Resistant Enterococci. European Journal of Clinical Microbiology & Infectious Diseases. 17(10). 734–736. 24 indexed citations

11.

Andreana, A, et al.. (1998). HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury. The American Journal of Gastroenterology. 93(11). 2162–2166. 22 indexed citations

12.

Andreana, A, et al.. (1996). Abnormal Expression of a 170-Kilodalton P-Glycoprotein Encoded by MDR1 Gene, a Metabolically Active Efflux Pump, in CD4 ⁺ and CD8 ⁺ T Cells from Patients with Human Immunodeficiency Virus Type 1 Infection. AIDS Research and Human Retroviruses. 12(15). 1457–1462. 43 indexed citations

13.

Rambaldi, Alessandro, et al.. (1995). Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp.. PubMed. 18(3). 319–23. 4 indexed citations

14.

Utili, Riccardo, et al.. (1995). Visceral leishmaniasis during pregnancy treated with meglumine antimoniate. Infection. 23(3). 182–183. 14 indexed citations

15.

Andreana, A, et al.. (1994). Salmonella typhimurium Activates Human Immunodeficiency Virus Type 1 in Chronically Infected Promonocytic Cells by Inducing Tumor Necrosis Factor-α Production. Biochemical and Biophysical Research Communications. 201(1). 16–23. 11 indexed citations

16.

Andreana, A, S Gollapudi, & Sudhir Gupta. (1994). Salmonella typhimurium Induces Expression of P Glycoprotein (Multidrug Resistance 1 Gene Product) in a Promonocytic Cell Line Chronically Infected with Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 169(4). 760–765. 8 indexed citations

17.

Russo, Gian Luigi, et al.. (1988). Studies on Human Serum 5′ -Deoxy-5′ -Methylthioadenosine Phosphorylase: Molecular Properties and Clinical Perspectives. Advances in experimental medicine and biology. 250. 229–238. 2 indexed citations

18.

Perna, P, et al.. (1983). [Sensitivity of bacteria exposed to subinhibitory concentrations of antibiotics to the action of serum and liver phagocytes].. PubMed. 59(11). 1683–6. 2 indexed citations

19.

Galante, Domenico, et al.. (1982). Decreased phagocytic and bactericidal activity of the hepatic reticuloendothelial system during chronic ethanol treatment and its restoration by levamisole.. PubMed. 32(3). 179–87. 26 indexed citations

20.

Utili, Riccardo, et al.. (1977). Clearance of viable Salmonella strains by the isolated, perfused rat liver: a study of serum and cellular factors involved and of the effect of treatments with carbon tetrachloride or Salmonella enteritidis lipopolysaccharide.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(2). 79–88. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact